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Abstract
Objective To review the evidence on diagnostic accuracy of red flag
signs and symptoms to screen for fracture or malignancy in patients
presenting with low back pain to primary, secondary, or tertiary care.
Design Systematic review.
Data sourcesMedline, OldMedline, Embase, and CINAHL from earliest
available up to 1 October 2013.
Inclusion criteria Primary diagnostic studies comparing red flags for
fracture or malignancy to an acceptable reference standard, published
in any language.
Review methods Assessment of study quality and extraction of data
was conducted by three independent assessors. Diagnostic accuracy
statistics and post-test probabilities were generated for each red flag.
ResultsWe included 14 studies (eight from primary care, two from
secondary care, four from tertiary care) evaluating 53 red flags; only five
studies evaluated combinations of red flags. Pooling of data was not
possible because of index test heterogeneity. Many red flags in current
guidelines provide virtually no change in probability of fracture or
malignancy or have untested diagnostic accuracy. The red flags with
the highest post-test probability for detection of fracture were older age
(9%, 95% confidence interval 3% to 25%), prolonged use of corticosteroid
drugs (33%, 10% to 67%), severe trauma (11%, 8% to 16%), and
presence of a contusion or abrasion (62%, 49% to 74%). Probability of
spinal fracture was higher when multiple red flags were present (90%,
34% to 99%). The red flag with the highest post-test probability for
detection of spinal malignancy was history of malignancy (33%, 22% to
46%).
ConclusionsWhile several red flags are endorsed in guidelines to
screen for fracture or malignancy, only a small subset of these have
evidence that they are indeed informative. These findings suggest a
need for revision of many current guidelines.
Introduction
Low back pain is a major cause of disability,1 leading to
considerable healthcare expenditure around the world, especially
in high income countries.2The difficulty in providing a definitive
diagnosis for most presentations of back pain has given rise to
the term “non-specific low back pain,” which is generally
considered to be benign and can be managed in a primary care
setting.3 Some patients, however, present with low back pain
as the initial manifestation of a more serious pathology, such
as malignancy, spinal fracture, infection, or cauda equina
syndrome. Spinal fracture andmalignancy are themost common
serious pathologies affecting the spine. In patients with low
back pain presenting to primary care, between 1% and 4% will
have a spinal fracture4 and in less than 1%malignancy, whether
primary tumour or metastasis, will be the underlying cause.5
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Identification of serious pathologies, when they exist, is
important in the clinical assessment and further assessment and
specific treatment is usually required, particularly for
malignancy.6 7 For instance, early detection of spinal malignancy
could prevent further spread of metastatic disease.8 Identification
of spinal fracture will prevent the prescription of treatment such
as manual therapy, which is contraindicated,9 as well as progress
the patient towards further testing and treatment of underlying
disease (such as osteoporosis). Despite the potential
consequences of a late or missed diagnosis of these serious
pathologies, their low prevalence in primary care settings does
not justify routine ancillary testing of patients presenting with
low back pain. For this reason, accurate screening tools to aid
clinical decisions about when to refer for further testing are
paramount.
Most clinical practice guidelines for back pain recommend the
use of red flags to help identify those patients with a higher
likelihood of spinal fracture or malignancy who then become
candidates for more extensive diagnostic investigations. There
is confusion, however, as the guidelines have produced different
lists of red flags to screen for spinal fracture and malignancy.
Eight of the guidelines6 10-16 investigated by Koes and colleagues
in their review of back pain guidelines,3 endorsed 26 red flags
for fracture and 27 for malignancy. None of the eight guidelines
endorsed the same set of red flags, for either condition, so it is
unclear what clinicians should use in clinical care. Additionally,
guidelines generally provide no information on diagnostic
accuracy of the endorsed red flags, which limits their value in
clinical decision making. Adding to the uncertainty, the same
agency can provide inconsistent information on red flags. For
example, the National Institute for Health and Care Excellence
clinical guideline on the early management of persistent
non-specific low back pain4 does not endorse red flags, whereas
the group’s clinical knowledge summary for the management
of low back pain does.17
To resolve the uncertainty around application of red flags in
clinical practice, we conducted two Cochrane diagnostic test
accuracy reviews assessing the accuracy of red flags to screen
for the most common forms of serious pathology—spinal
fracture and malignancy—in patients with low back pain.4 5We
have provided a distilled summary of both reviews to help guide
clinical decision making.
Methods
Data sources
For the Cochrane diagnostic test accuracy reviews, we searched
Medline, OldMedline, Embase, and CINAHL (Ebsco) for
eligible studies from the earliest record up to 7 March 2012.
The search was updated to include studies up to 1 October 2013.
The searches used combinations of terms related to the patient
population, history taking, physical examination, and the target
condition and was developed in collaboration with a medical
information specialist. Forward and backward citation searches
were completed.
Study selection
Primary diagnostic studies were considered if they looked at
the results of history taking or physical examination compared
with those of an acceptable reference standard, to identify spinal
fracture or spinal malignancy in adult patients presenting with
low back pain. Examples of reference standards include
diagnostic imaging to confirm the presence of spinal fracture,
primary malignancy, or metastases in the spine. Long term
follow-up (more than six months) of patients after the initial
consultation was also considered an appropriate reference
standard for both fracture and malignancy if suspected cases
identified during the follow-up period were confirmed by
medical review. Cohort and cross sectional studies of a
consecutive series of patients that presented sufficient data to
allow estimates of diagnostic accuracy (such as sensitivity and
specificity) were considered for eligibility. We considered
studies reported in abstracts or conference proceedings and full
journal publications in all languages and excluded studies in
which “global clinician judgment” was the only red flag
investigated. Four review authors (CMW, NH, and AD for
fracture; NH, RWJGO, and AD for malignancy) independently
applied the selection criteria to retrieved citations. Final selection
was based on a review of full publications. Disagreements were
resolved by consensus or by consulting other review authors in
cases of persisting disagreement.
Data extraction and quality assessment
Three review authors (CMW and NH for fracture; NH and
RWJGO for malignancy) independently extracted data on
selection of participants, the index test, reference test, flow of
participants, timing of the study, and diagnostic accuracy.
Review authors independently assessed the risk of bias of each
study using the QUality Assessment of Diagnostic Accuracy
Studies (QUADAS) checklist.18 We used the 11 item version
of the QUADAS recommended by the Cochrane Diagnostic
Test Accuracy Working Group.19 This checklist (see table A in
appendix) was used to classify each item as “yes” (adequately
dealt with); “no” (inadequately dealt with); or “unclear”
(inadequate detail presented to allow a judgment to be made).
Disagreements were resolved by consensus. Authors of the
current review who were involved in the original study were
not involved in data extraction or quality assessment of that
study.
Data synthesis and analysis
We generated diagnostic 2×2 tables to characterise diagnostic
accuracy. Because of the heterogeneity of tests, study settings,
and methods we could not pool results. We used Review
Manager 5.220 to calculate study specific estimates of sensitivity
and specificity with 95% confidence intervals and MetaDisc
1.421 to calculate likelihood ratios with 95% confidence intervals.
Post-test probability was determined with standard methods22 23
with the 95% confidence interval for post-test probability
determined with point estimate of pre-test probability and the
95% confidence interval of the likelihood ratio.
We compared the diagnostic accuracy of red flags against the
clinical practice guideline developed by Chou and colleagues6 24
for the American College of Physicians and American Pain
Society. The guideline provides advice on diagnostic
investigation based on various patterns of risk factors (red flags).
Results
Search results
The electronic database search and citation tracking identified
13 669 unique titles for fracture and 3092 for malignancy (fig
1⇓). After screening of titles and abstracts, we retrieved full text
copies of 68 articles relating to fracture and 70 full text articles
relating to malignancy. Fourteen discrete studies were included
in the reviews, of which eight related to fracture and nine related
to malignancy (three studies dealt with both conditions).
For each included study, details on the design, setting,
population, reference standard, index tests used, and definition
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of the target condition are provided in tables B and C in the
appendix. Most studies (eight) were set in primary care,7 25-31
two in secondary care,32 33 and the four remaining in tertiary
care (three in emergency departments34-36 and one in a spinal
surgical unit37). Three studies investigated red flags for both
fracture and malignancy.7 27 34 Five of the eight primary care
studies were prospective in design, and three were retrospective
chart reviews (two for fracture, one for malignancy). Standard
radiographs were the most common reference standard for
diagnosing fracture, and the most common reference standards
used for malignancy were magnetic resonance imaging or long
term clinical follow-up.
Quality assessment
Appendix table D shows the individual results of quality
assessment for included studies. The items that were not
adequately dealt with were: an acceptable delay between index
and reference tests, partial verification, differential verification,
reference standard blinding, reporting uninterpretable results,
and explaining withdrawals. Four criteria (acceptable delay
between tests, differential verification, reference blinding, and
explaining withdrawals) were often scored as “unclear,”
indicating that studies provided insufficient information. The
specific details and criteria used for imaging reference standards
to diagnose either condition (such as views taken or reporting
procedure), though present, were usually poorly described.
Diagnostic accuracy
Prevalence varied among studies for both fracture (primary care:
median 3.6%, interquartile range 1.8-4.3%; secondary/tertiary
care: 6.5%, 2.9-9.1%), and malignancy (primary care: 0.2%,
0.1-0.7%; secondary care: one study 7%; tertiary care: two
studies 1.5% and 5.9%). Point prevalence used to calculate
post-test probability in this reviewwas determined by extracting
prevalence from a reduced set of methodologically robust studies
for fracture7 33 35 and cancer,7 27 and by considering a value that
could be readily applied in the clinical setting (fracture: 1% for
primary care, 5% for secondary and tertiary care; malignancy:
0.5% for primary care, 1.5% for secondary and tertiary care).
The reviews identified 29 red flags to screen for fracture7 25-27 33-36
and 24 to screen for malignancy,7 27-32 34 37 with 13 (25%)
evaluated in more than one study. Only six studies reported on
the accuracy of combinations of red flags,7 25 33 35-37 and few
studies provided precise definitions for each red flag. Figures
2-5⇓⇓⇓⇓ show the positive and negative likelihood ratios and
associated post-test probabilities for each red flag. Figures 2
and 4 are confined to the red flags endorsed in the American
College of Physicians clinical practice guideline with additional
red flags identified in our review reported in figures 3 and 5.
The full diagnostic accuracy data, both raw data and calculated
statistics, are provided in appendix tables E-G.
Red flags for spinal fracture
Figure 2 ⇓presents the information on diagnostic accuracy data
for red flags recommended in the American College of
Physicians guideline. The first column contains the specific
wording of the red flag from the guideline and the next column
the specific wording of similar red flags evaluated in the
diagnostic studies. For each evaluated red flag we have provided
the positive and negative likelihood ratios, typical prevalence,
and post-test probability if the red flag is present or absent. We
found inconsistent descriptions between the red flags evaluated
in primary studies and those presented in the guideline. For
example, the American College of Physicians guideline red flag
“older age” (men aged >65, women aged >75) is compared with
the similar red flag (age >64, van den Bosch and colleagues25)
that had a positive likelihood ratio of 2.5 (95% confidence
interval 2.2. to 2.8) and negative likelihood ratio of 0.3 (0.2 to
0.5). As this study was conducted in primary care, the typical
prevalence was set at 1% and is represented by the vertical line
in the figure. The probability of fracture given the presence of
the red flag is 2% (95% confidence interval 2% to 3%). A
second study using the same red flag (age >64, Henschke and
colleagues7) found the probability of fracture given presence of
red flag to be 7% (4% to 13%).
Of the four red flags endorsed in the American College of
Physicians guideline we could find data only on older age,
trauma, and corticosteroid use and not on history of osteoporosis.
In general, the presence of these red flags increased the
likelihood of fracture by up to 15% (older age, trauma). The
exception was the red flag “prolonged corticosteroid use,”
which, when present, suggested a post-test probability of 33%
(95% confidence interval 10% to 67%) when positive.7 By
contrast, the American College of Physicians guideline uses the
red flag “corticosteroid use,” as studied by Deyo and Diehl27,
which, when present, results in a post-test probability of 4%
(0% to 44%).27
Figure 3⇓ shows the red flags not endorsed in the American
College of Physicians guideline. In general, when present, these
produce trivial increases in probability of fracture; few produced
a precise estimate beyond the pre-test prevalence. The exceptions
are contusion or abrasion reported by Patrick and colleagues
(62%, 95% confidence interval 49% to 74%, post-test
probability),35 the combination of red flags (any four of leg or
buttock pain, female, older age, BMI <23, gait abnormality, no
regular exercise, sitting pain, osteoarthritis) reported by Roman
and colleagues (34%, 24% to 45%, post-test probability),33 the
combination of red flags (any three of female, age >70, severe
trauma, prolonged use of corticosteroids) reported by Henschke
and colleagues (90%, 34% to 99%, post-test probability),7 and
trauma with neurological signs reported by Gibson and Zoltie
(43%, 11% to 82%, post-test probability).36
Red flags for spinal malignancy
Figure 4⇓ shows that of the red flags classified as “major risk”
in the American College of Physicians guideline, only data on
the red flag “history of cancer” are available. When present,
“history of cancer” suggests a post-test probability of 7% (95%
confidence interval 3% to 16%) in primary care,31 and 33%
(22% to 46%) in the emergency setting.34 Red flags classified
as “minor risk” in the American College of Physicians guideline
(older age, unexplained weight loss, and failure to improve after
one month) have post-test probability point estimates below
3%.27 29 31 32 37 Figure 5⇓ shows red flags not endorsed in the
American College of Physicians guideline; all seem
uninformative.30 31 37 The exception is neurological symptoms,
for which there are contradictory data.28 31
Discussion
The informativeness of the large number of red flags endorsed
in guidelines for the management of non-specific low back pain
in primary care3 varies substantially and many have poor or
untested diagnostic accuracy. Of the red flags for fracture, older
age, prolonged steroid use, severe trauma, and contusion or
abrasion increased the probability of fracture to between 10%
and 33%, while the presence of multiple red flags increased the
probability of fracture to between 42% and 90%. Of the red
flags for malignancy, “history of cancer” increased the
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probability of malignancy to between 7% and 33% while older
age, unexplained weight loss, and failure to improve after one
month have post-test probabilities below 3%.
Our results support the approach taken in the American College
of Physicians guideline, which provides a more focused list of
red flags than other guidelines, and emphasises consideration
of the low probability of disease (given the specific red flags
present) when making decisions about the need for, and timing
of, further diagnostic investigation. While older age, steroid
use, and severe trauma are endorsed by the guideline to screen
for fracture, the combined red flags prolonged steroid use and
contusion or abrasion are absent. Our results suggest
consideration of their inclusion when the guideline is revised.
Of red flags endorsed by the guideline to screen for malignancy,
a history of malignancy was the only red flag that was found to
increase the chance of malignancy to greater than 7%.7 31 Our
data show that all red flags endorsed in the guideline as “minor
risk” for cancer had post-test probabilities below 3%, supporting
the guideline’s distinction between major risk and minor risk
red flags for cancer.
Many guidelines contain no information on diagnostic accuracy
for individual red flags.12-14 16 38 For example, the European
guideline for the management of chronic non-specific low back
pain12 endorses 10 red flags for conditions including fracture
and malignancy: patient aged <20 or >55, non-mechanical pain,
thoracic pain, history of cancer, steroid use, structural changes,
general unwellness, loss of weight, and diffuse neurological
deficit. Of these, we found no evidence for the red flags age
<20 or general unwellness. The red flags age >55, thoracic pain,
non-mechanical pain (with movement), structural change
(scoliosis, kyphosis), and loss of weight were all uninformative,
with contradictory data on the red flag “diffuse neurological
deficit.” Only history of cancer and steroid use (prolonged) were
found to be informative.
In addition to endorsing red flags with low or no diagnostic
accuracy, we found guidelines that recommended immediate
referral to imaging if any red flag was present.13 14 39 For example
the West Australian Diagnostic Imaging Pathways Guideline39
advocates a larger list of red flags and directs clinicians to image
patients when even a single red flag is present. If this advice
was followed it would lead to substantial and arguably
unwarranted referrals for imaging as some of the endorsed red
flags are common (such as age <20 or >55)9 or uninformative
(such as thoracic pain, which has a positive likelihood ratio of
about 1 in screening for malignancy).31
Strengths and weaknesses of the review
We combined two previous reviews4 5 that followed published
pre-specified protocols40 41 and adopted the methods endorsed
by the Cochrane Collaboration to search for, appraise, and
summarise the evidence (http://srdta.cochrane.org/handbook-
dta-reviews). By illustrating the pre- and post-test probabilities
in figures we provide a simple method to describe the utility of
red flags to inform clinical decisions about their use in practice.
Also, the ability to view recommendations of guidelines in
conjunction with our diagnostic accuracy data provides insight
into the lack of standard for what constitutes a red flag.
A challenge in applying the results of diagnostic research in
practice is that some key statistics might be misunderstood by
clinicians.42 43 Provision of a list of red flags with sensitivity and
specificity values might therefore not be optimal. We have
graphically portrayed the post-test probability and 95%
confidence intervals for investigated red flags. The figures
enable clinicians to easily interpret the informativeness of red
flags to screen for spinal fracture and malignancy.44A limitation
of this approach is that prevalence of fracture and malignancy
varied considerably between studies (fracture from 0.7% to
11.0%; malignancy from 0% to 7.0%) and depended on study
methods and setting. Clinical and artefactual variability could
also have contributed to the differences in prevalence.45Because
of study heterogeneity and variability in quality, prevalence per
care setting was determined by using only the most
methodologically robust studies. Therefore values for prevalence
and post-test probability in our review might not generalise to
every setting. We have included sensitivities, specificities, and
likelihood ratios in the appendix for all red flags to enable
calculation of post-test probability for different prevalence rates.
There is still work to be done in determining the best approach
to bringing this information to the point of care.
Possible explanations and implications for
clinicians and policymakers
Unnecessary imaging is a concern inmany settings, with adverse
consequences for the patient and society.6 7 46-48 Our review
shows that the advice, provided in some guidelines, to refer all
patients with a single positive red flag for imaging is unwise.
Given that 80% of patients in primary care might have at least
one positive red flag,7 such a course would mean that most
patients with low back pain would receive diagnostic imaging.
In contrast, our review is consistent with the approach in the
guidelines of the American College of Physicians guideline and
others7 27 46 to first of all consider the probability of serious
disease (given the specific red flags present) when making
decisions about the need for and timing of imaging. Our results
suggest that many guidelines will need revision so that they
provide advice for practice that is more firmly grounded in the
relevant diagnostic research.
Unanswered questions and future research
Our review has highlighted the need for more high quality
diagnostic research on the topic. Much of the existing research
has evaluated single clinical features and our results suggest it
might be more useful to evaluate combinations of clinical
features, as is done with decision rules such as the Ottawa ankle
rule49 and Canadian C-Spine Rule.50 51 While some decision
rules are available,7 33 all are at the derivation stage and await
external validation. There is a need for systematic reviews of
red flags to screen for other conditions such as infection and
ankylosing spondylitis. Finally, consideration of the optimal
way to provide this information so that it is available to the
clinician at the point of care, in a readily understood format, is
an important topic for future research.
This review is adapted from two Cochrane reviews.4 5
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What is already known on this topic
Most clinical practice guidelines provide “red flags” to suggest a need to screen for spinal fracture or malignancy in patients presenting
with low back pain but do not agree on which ones to use
The total number of red flags endorsed in clinical guidelines is large
What this study adds
We identified the evidence for diagnostic accuracy of red flags for spinal fractures and spinal malignancies
Older age, prolonged corticosteroid use, severe trauma, and presence of a contusion or abrasion increased the likelihood of spinal
fracture; likelihood was higher with multiple red flags
Only a history of malignancy increased the likelihood of spinal malignancy
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Figures
Fig 1 Flow diagram of search strategies for studies evaluating red flags to screen for spinal fracture and malignancy in
patients presenting with low back pain
Fig 2 Diagnostic accuracy of red flags for spinal fracture included in American College of Physicians (ACP) guideline.
Vertical line indicates prevalence of spinal fracture: 1% in primary care, 5% in secondary and tertiary care. *Severe trauma:
trauma such as fall from height or motor vehicle crash (Deyo27); trauma which is major in young patients and minor in elderly
(Henschke7). †Minor trauma: in elderly women with osteoporosis (Scavone26). ‡Trauma: history of direct trauma (Gibson36);
history of trauma (Patrick,35 Reinus34). §History of osteoporosis not evaluated by any included study
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Fig 3 Diagnostic accuracy of red flags for spinal fracture excluded from American College of Physicians (ACP) guideline.
Vertical line indicates prevalence of spinal fracture: 1% in primary care, 5% in secondary and tertiary care. DTR=deep
tendon reflex; BMI=body mass index. *Motor deficit: weakness or atrophy. †Henschke index tests: female, age >70, severe
trauma, and prolonged use of corticosteroids. ‡Roman index tests: leg or buttock pain, sex, age, BMI, gait abnormality, no
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regular exercise, sitting pain, osteoarthritis. §Neurological signs or straight leg raise <40º. ¶Neurological deficit: consistent
with lumbar plexus distribution
Fig 4 Diagnostic accuracy of red flags for spinal malignancy included in American College of Physicians (ACP) guideline.
Vertical line indicates prevalence of spinal malignancy: 0.5% in primary care, 1.5% in secondary and tertiary care. *Included
studies for spinal malignancy did not investigate combination red flags. †Red flag “clinical suspicion” did not meet inclusion
criteria of either Cochrane review4 5
Fig 5Diagnostic accuracy of red flags for spinal malignancy excluded from American College of Physicians (ACP) guideline.
Vertical line indicates prevalence of spinal malignancy: 0.5% in primary care, 1.5% in secondary and tertiary care. *Absence
of pain during combined movements of flexion, extension and lateral flexion
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